Consensus guidelines for 'rainy day' autologous stem cell harvests in New South Wales

被引:5
作者
Trotman, J. [1 ]
Presgrave, P. [5 ]
Kwan, Y. [1 ]
Tiley, C. [6 ]
Estell, J. [1 ]
Watson, A. M. [2 ]
O'Brien, T. A. [3 ]
Peters, D. [4 ]
机构
[1] Concord Hosp, Dept Haematol, Concord, NSW, Australia
[2] Liverpool Hosp, Sydney, NSW, Australia
[3] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Concord, NSW, Australia
[4] BMT Network Secretariat, Sydney, NSW, Australia
[5] Wollongong Hosp, Wollongong, NSW, Australia
[6] Gosford Hosp, Gosford, NSW, Australia
关键词
rainy day; autologous stem cell; harvest; cryopreservation;
D O I
10.1111/j.1445-5994.2008.01632.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autologous stem cell transplantation (ASCT) has a well-established role in the treatment of haematological malignancies. Stem cells are commonly collected following salvage chemotherapy although there may be advantages in collecting earlier in the disease course. A 'rainy day' harvest (RDH) refers to the collection of autologous haemopoietic stem cells for long-term storage. Although there are few data to support RDH, there is increasing evidence that such harvests are being carried out, creating storage pressures in stem cell laboratories across New South Wales. The Bone Marrow Transplant Network New South Wales conducted a three-staged exercise to develop consensus-based RDH guidelines. Using available evidence, guidelines were developed supporting RDH for specific patients with acute and chronic myeloid leukaemias, follicular and other lymphomas, and multiple myeloma. Physician agreement with these disease-specific guidelines ranged between 58 and 100%. These consensus guidelines will improve equity of access to appropriate RDH and assist the planning of future storage requirements in New South Wales.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 24 条
[1]   Single versus double autologous stem-cell transplantation for multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Facon, T ;
Guilhot, F ;
Doyen, C ;
Fuzibet, JG ;
Monconduit, M ;
Hulin, C ;
Caillot, D ;
Bouabdallah, R ;
Voillat, L ;
Sotto, JJ ;
Grosbois, B ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2495-2502
[2]   A randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine [J].
Bradstock, KF ;
Matthews, JP ;
Lowenthal, RM ;
Baxter, H ;
Catalano, J ;
Brighton, T ;
Gill, D ;
Eliadis, P ;
Joshua, D ;
Cannell, P ;
Schwarer, AP ;
Durrant, S ;
Gillett, A ;
Koutts, J ;
Taylor, K ;
Bashford, J ;
Arthur, C ;
Enno, A ;
Dunlop, L ;
Szer, J ;
Leahy, M ;
Juneja, S ;
Young, GAR .
BLOOD, 2005, 105 (02) :481-488
[3]   GENE-MARKING TO TRACE ORIGIN OF RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRENNER, MK ;
RILL, DR ;
MOEN, RC ;
KRANCE, RA ;
MIRRO, J ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 341 (8837) :85-86
[4]   What is remission in follicular lymphoma and what is its relevance? [J].
Buckstein, R ;
Pennell, N ;
Berinstein, NL .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (01) :27-56
[5]   Primary mediastinal large B-cell lymphoma - A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (''Groupe d'Etude des Lymphomes de L'adulte'') study [J].
CazalsHatem, D ;
Lepage, E ;
Brice, P ;
Ferrant, A ;
dAgay, MF ;
Baumelou, E ;
Briere, J ;
Blanc, M ;
Gaulard, P ;
Biron, P ;
Schlaifer, D ;
Diebold, J ;
Audouin, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (07) :877-888
[6]   GENETIC MARKING SHOWS THAT PH(+) CELLS PRESENT IN AUTOLOGOUS TRANSPLANTS OF CHRONIC MYELOGENOUS LEUKEMIA (CML) CONTRIBUTE TO RELAPSE AFTER AUTOLOGOUS BONE-MARROW IN CML [J].
DEISSEROTH, AB ;
ZU, ZF ;
CLAXTON, D ;
HANANIA, EG ;
FU, SQ ;
ELLERSON, D ;
GOLDBERG, L ;
THOMAS, M ;
JANICEK, K ;
ANDERSON, WF ;
HESTER, J ;
KORBLING, M ;
DURETT, A ;
MOEN, R ;
BERENSON, R ;
HEIMFELD, S ;
HAMER, J ;
CALVERT, L ;
TIBBITS, P ;
TALPAZ, M ;
KANTARJIAN, H ;
CHAMPLIN, R ;
READING, C .
BLOOD, 1994, 83 (10) :3068-3076
[7]   Optimization of peripheral flood stem cell mobilization [J].
Demirer, T ;
Buckner, CD ;
Bensinger, WI .
STEM CELLS, 1996, 14 (01) :106-116
[8]   Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission [J].
Drummond, MW ;
Marin, D ;
Clark, RE ;
Byrne, JL ;
Holyoake, TL ;
Lennard, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) :479-483
[9]   Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: Saving for a rainy day [J].
Grupp, SA ;
Cohn, SL ;
Wall, D ;
Reynolds, CP .
PEDIATRIC BLOOD & CANCER, 2006, 46 (07) :719-722
[10]  
HAAS R, 1994, BLOOD, V83, P3787